Cytosorbents
CTSO
#9314
Rank
โ‚ฌ46.68 M
Marketcap
0,85ย โ‚ฌ
Share price
-2.83%
Change (1 day)
-28.29%
Change (1 year)

Revenue for Cytosorbents (CTSO)

Revenue in 2024 (TTM): โ‚ฌ30.54 Million

According to Cytosorbents's latest financial reports the company's current revenue (TTM ) is โ‚ฌ31.59 Million. In 2023 the company made a revenue of โ‚ฌ28.11 Million an increase over the revenue in the year 2022 that were of โ‚ฌ27.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytosorbents from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ30.54 M8.62%
2023 โ‚ฌ28.11 M2.74%
2022 โ‚ฌ27.37 M-22.72%
2021 โ‚ฌ35.41 M10.41%
2020 โ‚ฌ32.07 M57.83%
2019 โ‚ฌ20.32 M14.8%
2018 โ‚ฌ17.7 M58.73%
2017 โ‚ฌ11.15 M42.96%
2016 โ‚ฌ7.8 M110.32%
2015 โ‚ฌ3.7 M43.46%
2014 โ‚ฌ2.58 M334.5%
2013 โ‚ฌ0.59 M-250.38%
2012 -โ‚ฌ0.4 Million-1524.36%
2011 โ‚ฌ0.02 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.31 B 911.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.82 B 12,007.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.60 B 46,138.20%๐Ÿ‡บ๐Ÿ‡ธ USA